The role of urotensin II in the metabolic syndrome

This publication has 100 references indexed in Scilit:

• Exercise urotensin II dynamics in myocardial infarction survivors with and without hypertension
  International Journal of Cardiology, 2006
• Association of ACE, ACE2 and UTS2 Polymorphisms with Essential Hypertension in Han and Dongxiang Populations from North-western China
  Journal of International Medical Research, 2006
• Urotensin II is an inverse predictor of incident cardiovascular events in end-stage renal disease
  Kidney International, 2006
• Vascular contractile effect of urotensin II in young and aged rats: Influence of aging and contribution of endothelial nitric oxide
  Peptides, 2006
• Diagnosis and Management of the Metabolic Syndrome
  Circulation, 2005
• Human Urotensin II Accelerates Foam Cell Formation in Human Monocyte-Derived Macrophages
  Hypertension, 2005
• Elevated plasma human urotensin-II-like immunoreactivity in ischemic cardiomyopathy
  International Journal of Cardiology, 2004
• Urotensin II Acts Centrally to Increase Epinephrine and ACTH Release and Cause Potent Inotropic and Chronotropic Actions
  Hypertension, 2003
• The hypothalamus and the control of energy homeostasis
  Physiology & Behavior, 2001
• Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease; Edinburgh Artery Study Edinburgh Artery Study
  European Heart Journal, 1999